CA2333115A1 - Methode de detection de la toxicite cellulaire potentielle de composes - Google Patents
Methode de detection de la toxicite cellulaire potentielle de composes Download PDFInfo
- Publication number
- CA2333115A1 CA2333115A1 CA002333115A CA2333115A CA2333115A1 CA 2333115 A1 CA2333115 A1 CA 2333115A1 CA 002333115 A CA002333115 A CA 002333115A CA 2333115 A CA2333115 A CA 2333115A CA 2333115 A1 CA2333115 A1 CA 2333115A1
- Authority
- CA
- Canada
- Prior art keywords
- liposomes
- test medium
- test
- dye
- medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
L'invention concerne une procédure d'essai pour le criblage de la toxicité cellulaire potentielle d'un composé d'essai, comprenant les étapes suivantes: (a) fabrication de liposomes à partir d'un mélange de lipides, pour la simulation d'une composition de membrane cellulaire à analyser, les liposomes étant fabriqués dans un milieu aqueux ayant un pH correspondant ainsi au pH intérieur des liposomes; (b) incorporation des liposomes à un milieu d'essai aqueux ayant un pH d'au moins environ 0,5 pH unités supérieur au pH intérieur des liposomes, un gradient de pH existant entre le milieu d'essai et l'intérieur des liposomes; (c) incorporation d'un pigment fluorescent au milieu d'essai, le pigment ayant tendance à pénétrer dans les liposomes en raison du gradient de pH et étant sensible au pH de sorte que la fluorescence du pigment soit éliminée à l'intérieur des liposomes; (d) incorporation du composé d'essai au milieu d'essai; si le composé d'essai interrompt la structure des liposomes ou induit la dissipation du gradient de pH entre le milieu d'essai et l'intérieur des liposomes, la fluorescence du pigment n'est pas éliminée; (e) détermination de la fluorescence du milieu d'essai et comparaison avec celle des témoins.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8797798P | 1998-06-04 | 1998-06-04 | |
| US60/087,977 | 1998-06-04 | ||
| PCT/IB1999/000998 WO1999063343A1 (fr) | 1998-06-04 | 1999-06-01 | Methode de detection de la toxicite cellulaire potentielle de composes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2333115A1 true CA2333115A1 (fr) | 1999-12-09 |
Family
ID=22208381
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002333115A Abandoned CA2333115A1 (fr) | 1998-06-04 | 1999-06-01 | Methode de detection de la toxicite cellulaire potentielle de composes |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1084405A1 (fr) |
| JP (1) | JP2002517726A (fr) |
| AU (1) | AU3842699A (fr) |
| CA (1) | CA2333115A1 (fr) |
| IL (1) | IL139746A0 (fr) |
| NO (1) | NO20006125L (fr) |
| WO (1) | WO1999063343A1 (fr) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2642526B1 (fr) * | 1989-01-27 | 1992-11-13 | Spiral Rech & Dev | Utilisation de generateur de radicaux libres dans le domaine des dosages biologiques |
-
1999
- 1999-06-01 CA CA002333115A patent/CA2333115A1/fr not_active Abandoned
- 1999-06-01 AU AU38426/99A patent/AU3842699A/en not_active Abandoned
- 1999-06-01 EP EP99921069A patent/EP1084405A1/fr not_active Withdrawn
- 1999-06-01 WO PCT/IB1999/000998 patent/WO1999063343A1/fr not_active Ceased
- 1999-06-01 IL IL13974699A patent/IL139746A0/xx unknown
- 1999-06-01 JP JP2000552499A patent/JP2002517726A/ja not_active Withdrawn
-
2000
- 2000-12-01 NO NO20006125A patent/NO20006125L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20006125L (no) | 2001-02-02 |
| WO1999063343A1 (fr) | 1999-12-09 |
| NO20006125D0 (no) | 2000-12-01 |
| IL139746A0 (en) | 2002-02-10 |
| EP1084405A1 (fr) | 2001-03-21 |
| JP2002517726A (ja) | 2002-06-18 |
| AU3842699A (en) | 1999-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Duzgunes et al. | Lipid mixing during membrane aggregation and fusion: why fusion assays disagree | |
| Stubbs et al. | Microviscosity of the hydrocarbon region of the bovine retinal rod outer segment disk membrane determined by fluorescent probe measurements | |
| Ruokonen et al. | Correlation between ionic liquid cytotoxicity and liposome–ionic liquid interactions | |
| Marchi‐Artzner et al. | Selective adhesion, lipid exchange and membrane‐fusion processes between vesicles of various sizes bearing complementary molecular recognition groups | |
| Chalpin et al. | Interaction of fluorescence quenchers with the n-(9-anthroyloxy) fatty acid membrane probes | |
| US6984528B2 (en) | Method for detecting an analyte by fluorescence | |
| US7514267B1 (en) | Detection systems utilizing supported lipid bilayers | |
| Alvarez et al. | Binding of sea anemone pore-forming toxins sticholysins I and II to interfaces—modulation of conformation and activity, and lipid–protein interaction | |
| Anzai et al. | Change in intravesicular volume of liposomes by freeze-thaw treatment as studied by the ESR stopped-flow technique | |
| Jansson et al. | Osmotic water permeabilities of human placental microvillous and basal membranes | |
| Matayoshi | Distribution of shape-changing compounds across the red cell membrane | |
| Pal et al. | Characterization of the fluorophore 4-heptadecyl-7-hydroxycoumarin: a probe for the head-group region of lipid bilayers and biological membranes | |
| US20090062141A1 (en) | Method for evaluating drug candidates | |
| Madhavan et al. | Increasing pH Causes Faster Anion‐and Cation‐Transport Rates through a Synthetic Ion Channel | |
| Lentz et al. | Phase behavior of mixed phosphatidylglycerol/phosphatidylcholine multilamellar and unilamellar vesicles | |
| Verkman | The quenching of an intramembrane fluorescent probe. A method to study the binding and permeation of phloretin through bilayers | |
| CA2333115A1 (fr) | Methode de detection de la toxicite cellulaire potentielle de composes | |
| Helgerson et al. | Changes in Escherichia coli cell envelope structure and the sites of fluorescence probe binding caused by carbonyl cyanide p-trifluoromethoxyphenylhydrazone | |
| Song et al. | Detection of multivalent interactions through two-tiered energy transfer | |
| Leevy et al. | NMR and ion selective electrode studies of hydraphile channels correlate with biological activity in E. coli and B. subtilis | |
| US20070172813A1 (en) | Method for Evaluating Drug Candidates | |
| Desai et al. | Ionization and adsorption of a series of local anesthetics in detergent micelles: studies of drug fluorescence. | |
| Yoda | Direct Observation of Cell‐sized Liposomes Containing a Functional Polyphenol Procyanidin B2 from Apple | |
| Rashid et al. | Effect of pH and temperature on the binding of bilirubin to human erythrocyte membranes | |
| EP1161688B1 (fr) | Procede de detection colorimetrique |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |